First Time Loading...

Iovance Biotherapeutics Inc
NASDAQ:IOVA

Watchlist Manager
Iovance Biotherapeutics Inc Logo
Iovance Biotherapeutics Inc
NASDAQ:IOVA
Watchlist
Price: 7.78 USD -4.42% Market Closed
Updated: Jun 9, 2024
IOVA
/
Cash Flow Statement
/
Cash from Financing Activities

Iovance Biotherapeutics Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Iovance Biotherapeutics Inc
Cash from Financing Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Iovance Biotherapeutics Inc
NASDAQ:IOVA
Cash from Financing Activities
$398.4m
CAGR 3-Years
-14%
CAGR 5-Years
9%
CAGR 10-Years
33%
Abbvie Inc
NYSE:ABBV
Cash from Financing Activities
-$211m
CAGR 3-Years
74%
CAGR 5-Years
59%
CAGR 10-Years
24%
Gilead Sciences Inc
NASDAQ:GILD
Cash from Financing Activities
-$5.1B
CAGR 3-Years
N/A
CAGR 5-Years
9%
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Cash from Financing Activities
-$2.2B
CAGR 3-Years
31%
CAGR 5-Years
33%
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Financing Activities
-$625m
CAGR 3-Years
2%
CAGR 5-Years
-27%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Financing Activities
-$1.4B
CAGR 3-Years
19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Iovance Biotherapeutics Inc's Cash from Financing Activities?
Cash from Financing Activities
398.4m USD

Based on the financial report for Mar 31, 2024, Iovance Biotherapeutics Inc's Cash from Financing Activities amounts to 398.4m USD.

What is Iovance Biotherapeutics Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
33%

Over the last year, the Cash from Financing Activities growth was -11%. The average annual Cash from Financing Activities growth rates for Iovance Biotherapeutics Inc have been -14% over the past three years , 9% over the past five years , and 33% over the past ten years .

ALPHA SPREAD
Join more than 145,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.